• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Frequent Platelet Donation and Risk for T-cell Lymphopenia

November 22, 2023

In the United States, over 90% of platelets are collected by plateletpheresis, and donors may give platelets up to 24 times annually.  Recent studies, however, have observed that frequent platelet donors may develop lymphopenia. To gain a better understanding of risk factors for T-cell lymphopenia in frequent platelet donors (who have donated platelets at least 20 times within the past 12 months), researchers compared CD4+ T-cell counts in frequent platelet donors who donated exclusively using the Trima instrument (n=133) or the Amicus instrument (n=77).  Whole blood donors matched by age and sex were used as controls (n=126).  At enrollment, 9.9% and 4.4% of frequent Trima (LRS+) and Amicus platelet donors had CD4+ T-cell counts <200 cells/µL, respectively, compared to no whole blood donors. Older age, an increased number of donations, and collection using the Trima instrument were identified as risk factors for developing T-cell lymphopenia.  However, the risk of developing lymphopenia may be decreased by using a plasma rinseback procedure with the Trima instrument.  While the clinical significance of lymphopenia from platelet donations is unclear, platelet donors should be made aware of this risk.

Reference:

Kaufman RM, Marks DC, Flamand Y, Acker JP, Brown BL, Olafson C, Marschner S, Pandey S, Papari M, Petraszko T, Serrano K, Ward D, Bazin R; Biomedical Excellence for Safer Transfusion Collaborative. Risk factors for T-cell lymphopenia in frequent platelet donors: The BEST collaborative study. Transfusion. 2023 Nov;63(11):2072-2082.

Filed Under

  • Blood Donation
  • News

Recommended

  • Sutimlimab, a Monoclonal Antibody, to Treat Cold Agglutinin Disease

  • Peginesatide Recalled After Serious Reactions Reported

  • Platelet transfusions are not recommended to treat cerebral hemorrhage for patients taking antiplatelet therapy

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Multifaceted Threats to the Blood Supply from Climate Change

  • Distinct Roles for Differently Aged Platelets

  • Anemia Treatment Bundle Improves Hemoglobin Recovery after Critical Illness

  • Prothrombin Complex Concentrate Is Safe and Effective for Cardiac Surgery Patients with Coagulopathic Bleeding

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley